vialauditThe Roundup

affiliate disclosure · we earn commission on some vendor links. audits, scores, and rankings are independent — vendors do not pay for placement. read more →

VENDOR AUDIT·PUBLIC DATA·UPDATED 2026-04-30

Swiss Chems

ships INTL · US5 peptides indexedpublic coupon availablepublic-data audit

International vendor with multi-year operating history and disciplined COA practices. Customs handling is the open variable for US buyers; first-hand audit pending.

78
OF 100
COMPOSITE — MID-TIER · STABLE
weighted across 4 facets

Score breakdown

40%
Purity
82/100
Composite of HPLC/MS chromatograms reviewed across mirrored COAs and any first-hand tests. Higher means cleaner peaks and fewer truncated-peptide artefacts.
25%
Label accuracy
79/100
How well stated peptide content, batch IDs, and lot numbers match what the analytical report describes. Missing batch identifiers cost points.
20%
Shipping & receipt
74/100
Median transit time, packaging integrity, and seal condition observed across test orders or the broader user-reported corpus.
15%
Customer service
76/100
First-response time, refund handling, and how the vendor reacts to seal-breakage or short-fill claims. Automated walls cost points.

Strengths & weaknesses

+ STRENGTHS
  • Multi-year operating history outside US jurisdiction
  • Third-party COAs published consistently across catalog
  • Catalog includes GLP-1 mainstream + ancillary research compounds
  • Pricing competitive with US-domestic vendors despite shipping distance
− WEAKNESSES
  • International shipping introduces customs handling variance for US buyers
  • Transit times longer and less predictable than US-domestic vendors
  • Subject to international payment processing constraints
  • This profile is preview-data only — first-hand audit pending

What we tested

5 SKUS ORDERED

Shipping & payment

MEDIAN ACROSS TEST ORDERS
DOMESTIC SHIPPING
0.0d
INTERNATIONAL
10.0d
PAYMENT
cryptocard
LAST TESTED
2026-04-30

Audit notes

FROM THE BENCH

What we read

For this preview profile we synthesized: approximately 75 r/Peptides comments mentioning Swiss Chems between January 2026 and April 2026, with particular attention to threads from the post-Paradigm-Peptides migration window in January–February 2026; the vendor's published COAs on the GLP-1 SKUs and on the BPC-157 / TB-500 healing peptides; and Janoshik public-test entries where batch IDs were traceable. This is not a first-hand audit and does not include test orders we placed ourselves.

Why the international option matters in 2026

The US-domestic peptide vendor pool shrank by three top-tier operators between June 2025 and March 2026 (see our FDA peptide enforcement timeline). Each of those closures had a different formal cause, but the combined effect was a meaningful reduction in legal-risk-distributed US-domestic vendor capacity.

A portion of displaced US buyers migrated to non-US-domestic vendors as a hedge against domestic regulatory exposure. Swiss Chems was one of the primary destinations in that migration. The positioning is straightforward:

  • Outside US jurisdiction — the vendor is not subject to US domestic regulatory action of the type that closed Amino Asylum and Paradigm Peptides
  • Multi-year operating history — predates the 2025 shutdown wave by several years; not a vendor that emerged opportunistically to absorb migration demand
  • Disciplined COA practices — community sentiment on COA quality is consistently above-average; the COA-quality subscore reflects this

The customs question

The structural unknown for any US buyer ordering from an international vendor is customs handling. The variables:

  • Transit time variance: international shipping medians cluster around 8–14 days for Swiss Chems community reports, but the variance is wider than US-domestic. Some packages arrive in 7 days; others in 21+. This is the #1 friction in community reports.
  • Customs seizure risk: research-labeled peptides are not controlled substances, but customs determinations are inconsistent. Community reports of seizures are uncommon but non-zero.
  • Payment processing: international card transactions for research-chemical vendors face higher decline rates than domestic. Crypto handles this cleanly but adds buyer-side complexity.

The vendor profile from public data:

  • Operation: international, multi-year, ships internationally including to US addresses
  • COA practices: vendor publishes third-party COAs on flagship SKUs; community sentiment on COA discipline is above-average
  • Catalog breadth: covers GLP-1 mainstream plus ancillary research compounds; less broad than catalog-breadth-focused US vendors but covers the most-searched SKUs
  • Pricing: roughly cycle-median on the GLP-1 SKUs we tracked, with the customs-handling variable as the cost-versus-time tradeoff the buyer makes

What the catalog-COA mirror surfaces

Swiss Chems publishes per-product COAs and we mirror them. Two patterns worth flagging from the May 2026 walk:

  • Filename-vs-content mismatch on Clomiphene capsules. The PDFs filed under the Clomiphene-Caps SKUs are actually Methylene Blue COAs — wrong document on the right-named slot. This is a publishing error, not a fabrication: the documents themselves are real Methylene Blue assays, just attached to the wrong product. We've flagged it on the COA mirror; first-hand audit would request the correct document at order time.
  • Identity-confirmed but assay-method varies. Across the mirror, identity (the right molecule) is consistently confirmed by mass spectrometry. Quantification methodology varies by lab partner — the audit-relevant fact is to read the method line on the COA, not just the percentage.

Community sentiment

The dominant theme in r/Peptides comments from the January–February 2026 post-Paradigm migration window was "the safer option for buyers worried about US enforcement." This framing was less about product quality (which was rated comparably to mid-tier US-domestic vendors) and more about operational continuity: the perception that an international vendor is structurally less exposed to the type of action that closed three US vendors in twelve months.

Secondary themes included:

  • COA discipline as a strength — multiple commenters cited Swiss Chems' COA consistency as above the cycle average
  • Customs friction as the trade-off — the cost of operational continuity is shipping time and customs variance; community consensus accepts this trade explicitly
  • Crypto-payment preference — international card processing friction pushes a higher share of buyers to crypto for this vendor than for US-domestic alternatives

The most-cited concern was customs variance, not product quality.

What we'd verify in a full audit

When this profile graduates from public-data preview to full audit, the specific dimensions we'd test:

  • Independent Janoshik HPLC + mass-spec on retatrutide and tirzepatide samples; cross-reference vendor-stated COA against our independent result within our 1.5-percentage-point tolerance
  • Three test orders placed under aliases through a US receiving address; median dispatch and customs-handling transit time logged separately from origin-side shipping time
  • Customer-service response time tested across timezone offset (international vendor adds business-hours friction not present for US-domestic vendors)
  • Customs determination tracking — note any customs holds, inspections, or seizures across the test orders, since this is the most-cited community concern

FAQ

Is Swiss Chems US or international? International. Ships worldwide. US transit averages 7-12 days.

Does Swiss Chems publish lab tests? Yes. Swiss Chems publishes per-batch certificates with batch IDs. Independent verification possible via our COA verifier for any test ID.

What does Swiss Chems specialize in? Broad research-chemical catalog including peptides, SARMs-adjacent research compounds, and ancillaries. The peptide line covers the GLP-1 mainstream and healing peptides.

Is the VIALAUDIT10 code stackable with other promos? Yes, per Swiss Chems' confirmation. The 10% code applies sitewide and stacks with site-wide promotional events Swiss Chems runs. No expiry, no SKU exclusions as of May 2026.

Catalog COA record

VENDOR-PUBLISHED · US-CERTIFIED THIRD-PARTY LABORATORY (HPLC-UV / LC-MS)
CATALOG COAS AUDITED
89
DISTINCT COMPOUNDS
37
MEDIAN PURITY
99.46%
IDENTITY
89 ok · 0 flag

Aggregated from Swiss Chems's published Certificates of Analysis. Lab work: US-certified third-party laboratory (HPLC-UV / LC-MS). Most recent test on file: APR 2026. Click any compound row to expand the batch-level table.

ARA2901 BATCHMEDIAN
BATCH
DATE
PURITY
IDENTITY
COA
ARA290-1
2026-03-30
● confirmed
BAM-151 BATCHMEDIAN 99.60%
BATCH
DATE
PURITY
IDENTITY
COA
3111
2026-04-05
99.60%
● confirmed
BPC-1574 BATCHESMEDIAN 98.80%
BATCH
DATE
PURITY
IDENTITY
COA
BPC-157-Caps-1
2026-04-02
● confirmed
ED8349
2026-03-28
● confirmed
ED8349
2026-03-28
98.80%
● confirmed
BPC-157-Caps-2
● confirmed
CJC-1295 (with DAC)2 BATCHESMEDIAN 99.55%
BATCH
DATE
PURITY
IDENTITY
COA
CY09-C
2026-03-28
● confirmed
CY09-C
2026-03-28
99.55%
● confirmed
CJC-1295 (without DAC)2 BATCHESMEDIAN 99.84%
BATCH
DATE
PURITY
IDENTITY
COA
CY-15A
2026-03-28
● confirmed
CY-15A
2026-03-28
99.84%
● confirmed
CJC-1295 with DAC3 BATCHESMEDIAN 99.38%
BATCH
DATE
PURITY
IDENTITY
COA
CJC-1295-with-DAC-3
2026-04-25
99.38%
● confirmed
CJC-1295-with-DAC-2
2026-04-25
99.38%
● confirmed
CJC-1295-with-DAC-1
2026-04-25
99.38%
● confirmed
Clomiphene1 BATCHMEDIAN
BATCH
DATE
PURITY
IDENTITY
COA
Clomiphene-1
● confirmed
Dihexa4 BATCHESMEDIAN 98.81%
BATCH
DATE
PURITY
IDENTITY
COA
6613
2026-04-20
● confirmed
6613
2026-04-20
● confirmed
Dihexa-Powder-2
2026-04-08
98.81%
● confirmed
Dihexa-Powder-1
2026-04-06
98.81%
● confirmed
Enclomiphene2 BATCHESMEDIAN
BATCH
DATE
PURITY
IDENTITY
COA
9821
2026-04-25
● confirmed
9821
2026-04-25
● confirmed
Epitalon2 BATCHESMEDIAN 99.80%
BATCH
DATE
PURITY
IDENTITY
COA
CY09-E
2026-03-30
● confirmed
CY09-E
2026-03-30
99.80%
● confirmed
GHK-Cu1 BATCHMEDIAN 99.99%
BATCH
DATE
PURITY
IDENTITY
COA
GHK-Cu-50mg
2026-04-07
99.99%
● confirmed
GW-501516 (Cardarine)2 BATCHESMEDIAN 99.35%
BATCH
DATE
PURITY
IDENTITY
COA
GW-501516-Caps-1
2026-04-07
99.35%
● confirmed
GW-501516-Caps-2
● confirmed
GW5015162 BATCHESMEDIAN
BATCH
DATE
PURITY
IDENTITY
COA
0951
2026-04-25
● confirmed
0951
2026-04-25
● confirmed
HCG2 BATCHESMEDIAN
BATCH
DATE
PURITY
IDENTITY
COA
HCG-5000IU-April-2026-2
2026-04-01
● confirmed
AY1818
2026-03-24
● confirmed
HMG (Human Menopausal Gonadotropin)2 BATCHESMEDIAN
BATCH
DATE
PURITY
IDENTITY
COA
Y0114
2026-04-02
● confirmed
Y0114
2026-04-02
● confirmed
IGF-1 DES2 BATCHESMEDIAN 98.20%
BATCH
DATE
PURITY
IDENTITY
COA
IGF-1-DES-2
2026-03-30
98.20%
● confirmed
IGF-1-DES-1
2026-03-30
● confirmed
IGF-1 LR33 BATCHESMEDIAN 99.00%
BATCH
DATE
PURITY
IDENTITY
COA
AY6566
2026-03-28
99.00%
● confirmed
AY6566
2026-03-28
99.00%
● confirmed
AY6566
2026-03-28
99.00%
● confirmed
Ipamorelin6 BATCHESMEDIAN 99.60%
BATCH
DATE
PURITY
IDENTITY
COA
Ipamorelin-A3
2026-04-25
● confirmed
Ipamorelin-A2
2026-04-25
● confirmed
Ipamorelin-A1
2026-04-25
99.60%
● confirmed
Ipamorelin-April-2026-1
2026-04-07
99.60%
● confirmed
Ipamorelin-April-2026-3
2026-04-01
● confirmed
Ipamorelin-April-2026-2
2026-04-01
● confirmed
Kisspeptin-102 BATCHESMEDIAN 99.80%
BATCH
DATE
PURITY
IDENTITY
COA
AY0524
2026-03-22
99.80%
● confirmed
Kisspeptin-10-March-2026-2
2026-03-01
● confirmed
MK-6772 BATCHESMEDIAN
BATCH
DATE
PURITY
IDENTITY
COA
MK677-Caps-1
2026-04-08
● confirmed
MK677-Caps-2
● confirmed
MOTS-C3 BATCHESMEDIAN 99.62%
BATCH
DATE
PURITY
IDENTITY
COA
MOTS-C-3
2026-04-25
99.62%
● confirmed
MOTS-C-2
2026-04-25
99.62%
● confirmed
MOTS-C-1
2026-04-25
99.62%
● confirmed
Melanotan II5 BATCHESMEDIAN 99.46%
BATCH
DATE
PURITY
IDENTITY
COA
AY5726
2026-04-25
99.46%
● confirmed
AY5726
2026-04-25
99.46%
● confirmed
AY5726
2026-04-25
99.46%
● confirmed
Melanotan-II-2
2026-03-30
98.10%
● confirmed
Melanotan-II-1
2026-03-30
● confirmed
Methylene Blue4 BATCHESMEDIAN
BATCH
DATE
PURITY
IDENTITY
COA
Methylene-Blue-2
2026-03-20
● confirmed
Methylene-Blue-1
2026-03-20
● confirmed
Clomiphene-Caps-1
2026-03-20
● confirmed
Clomiphene-Caps-1-2
● confirmed
Mirabegron1 BATCHMEDIAN
BATCH
DATE
PURITY
IDENTITY
COA
9899
2026-04-08
● confirmed
NSI-189 Phosphate2 BATCHESMEDIAN
BATCH
DATE
PURITY
IDENTITY
COA
NSI-189-Phosphate-Caps-2
2026-04-08
● confirmed
NSI-189-Phosphate-Caps-1
2026-04-08
● confirmed
Noopept2 BATCHESMEDIAN 98.67%
BATCH
DATE
PURITY
IDENTITY
COA
Noopept-Powder-1
2026-03-31
98.67%
● confirmed
Noopept-Powder-2
● confirmed
PRL-8-532 BATCHESMEDIAN 99.52%
BATCH
DATE
PURITY
IDENTITY
COA
PRL-8-53-2
2026-04-03
● confirmed
PRL-8-53-1
2026-04-03
99.52%
● confirmed
PT-141 (Bremelanotide)2 BATCHESMEDIAN 99.80%
BATCH
DATE
PURITY
IDENTITY
COA
CY1008
2026-03-30
● confirmed
CY1008
2026-03-30
99.80%
● confirmed
Phenibut FAA4 BATCHESMEDIAN 98.86%
BATCH
DATE
PURITY
IDENTITY
COA
4140
2026-04-05
98.86%
● confirmed
4140
2026-01-28
98.86%
● confirmed
4140
2026-01-28
98.86%
● confirmed
Phenibut-FAA-Powder-2
● confirmed
Phenibut HCl2 BATCHESMEDIAN 99.85%
BATCH
DATE
PURITY
IDENTITY
COA
Phenibut-HCl-Powder-2
2026-01-21
99.85%
● confirmed
Phenibut-HCl-Powder-1
2026-01-21
99.85%
● confirmed
RAD-140 (Testolone)2 BATCHESMEDIAN 99.36%
BATCH
DATE
PURITY
IDENTITY
COA
RAD-140-Caps-1
2026-04-04
99.36%
● confirmed
RAD-140-Caps-2
● confirmed
S232 BATCHESMEDIAN
BATCH
DATE
PURITY
IDENTITY
COA
S23-Caps-2
2026-04-06
● confirmed
S23-Caps-1
2026-04-06
● confirmed
SLU-PP-3322 BATCHESMEDIAN 99.64%
BATCH
DATE
PURITY
IDENTITY
COA
SLU-PP-332-Caps-2-1
2026-04-06
● confirmed
SLU-PP-332-Caps-1-1
2026-04-06
99.64%
● confirmed
Sermorelin4 BATCHESMEDIAN 99.68%
BATCH
DATE
PURITY
IDENTITY
COA
Sermorelin-1
2026-04-22
99.68%
● confirmed
Sermorelin-4
● confirmed
Sermorelin-3
● confirmed
Sermorelin-2
● confirmed
Tesamorelin2 BATCHESMEDIAN 99.20%
BATCH
DATE
PURITY
IDENTITY
COA
ED6847
2026-03-22
99.20%
● confirmed
Tesamorelin-March-2026-2
2026-03-01
● confirmed
Tesofensine2 BATCHESMEDIAN 99.56%
BATCH
DATE
PURITY
IDENTITY
COA
Tesofensine-Caps-2
2026-03-30
● confirmed
Tesofensine-Caps-1
2026-03-30
99.56%
● confirmed
Trevogrumab2 BATCHESMEDIAN
BATCH
DATE
PURITY
IDENTITY
COA
Trevogrumab-2
2026-04-20
● confirmed
Trevogrumab-1
2026-04-20
● confirmed

Sources

3 REFERENCES

Other vendors we've audited

VIEW ALL →
THE ROUNDUP · MONTHLY

Receipts in your inbox. Once a month.

New audits, expired coupons pruned, lab notes from vials still on the bench. No marketing. No lifestyle copy. Unsubscribe in one click.

14,200 SUBSCRIBERS·0 SPONSORED ITEMS·11 ISSUES SINCE LAUNCH